Ledyard National Bank’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $250K | Sell |
474
-187
| -28% | -$105K | 0.02% | 229 |
|
|
2026
Q1 | $371K | Sell |
661
-65
| -9% | -$41.7K | 0.03% | 175 |
|
|
2025
Q4 | $491K | Buy |
+726
| New | +$494K | 0.04% | 151 |
|
|
2022
Q2 | – | Sell |
-540
| Closed | -$295K | – | 219 |
|
|
2022
Q1 | $295K | Hold |
540
| – | – | 0.03% | 191 |
|
|
2021
Q4 | $356K | Hold |
540
| – | – | 0.03% | 185 |
|
|
2021
Q3 | $336K | Sell |
540
-365
| -40% | -$245K | 0.03% | 190 |
|
|
2021
Q2 | $571K | Hold |
905
| – | – | 0.06% | 149 |
|
|
2021
Q1 | $443K | Sell |
905
-50
| -5% | -$25.1K | 0.05% | 164 |
|
|
2020
Q4 | $477K | Sell |
955
-50
| -5% | -$22.4K | 0.05% | 152 |
|
|
2020
Q3 | $395K | Hold |
1,005
| – | – | 0.05% | 161 |
|
|
2020
Q2 | $332K | Hold |
1,005
| – | – | 0.04% | 175 |
|
|
2020
Q1 | $243K | Hold |
1,005
| – | – | 0.04% | 209 |
|
|
2019
Q4 | $262K | Hold |
1,005
| – | – | 0.03% | 235 |
|
|
2019
Q3 | $273K | Hold |
1,005
| – | – | 0.04% | 229 |
|
|
2019
Q2 | $277K | Sell |
1,005
-50
| -5% | -$12.3K | 0.04% | 230 |
|
|
2019
Q1 | $236K | Sell |
1,055
-25
| -2% | -$5.16K | 0.03% | 251 |
|
|
2018
Q4 | $201K | Hold |
1,080
| – | – | 0.03% | 266 |
|
|
2018
Q3 | $270K | Hold |
1,080
| – | – | 0.03% | 254 |
|
|
2018
Q2 | $235K | Sell |
1,080
-125
| -10% | -$25.8K | 0.03% | 270 |
|
|
2018
Q1 | $231K | Sell |
1,205
-90
| -7% | -$16.6K | 0.03% | 281 |
|
|
2017
Q4 | $203K | Buy |
1,295
+480
| +59% | +$75.6K | 0.02% | 301 |
|
|
2017
Q3 | $127K | Sell |
815
-904
| -53% | -$143K | 0.02% | 338 |
|
|
2017
Q2 | $277K | Sell |
1,719
-140
| -8% | -$22.7K | 0.04% | 239 |
|
|
2017
Q1 | $287K | Hold |
1,859
| – | – | 0.04% | 223 |
|
|
2016
Q4 | $218K | Hold |
1,859
| – | – | 0.04% | 189 |
|
|
2016
Q3 | $210K | Sell |
1,859
-200
| -10% | -$21.1K | 0.04% | 191 |
|
|
2016
Q2 | $191K | Sell |
2,059
-600
| -23% | -$51.5K | 0.03% | 191 |
|
|
2016
Q1 | $208K | Buy |
2,659
+1,865
| +235% | +$134K | 0.04% | 186 |
|
|
2015
Q4 | $58K | Buy |
794
+200
| +34% | +$14.3K | 0.01% | 294 |
|
|
2015
Q3 | $44K | Buy |
594
+450
| +313% | +$32.2K | 0.01% | 310 |
|
|
2015
Q2 | $9K | Hold |
144
| – | – | ﹤0.01% | 531 |
|
|
2015
Q1 | $11K | Hold |
144
| – | – | ﹤0.01% | 484 |
|
|
2014
Q4 | $11K | Hold |
144
| – | – | ﹤0.01% | 509 |
|
|
2014
Q3 | $8K | Hold |
144
| – | – | ﹤0.01% | 491 |
|
|
2014
Q2 | $10K | Hold |
144
| – | – | ﹤0.01% | 486 |
|
|
2014
Q1 | $9K | Hold |
144
| – | – | ﹤0.01% | 480 |
|
|
2013
Q4 | $8K | Buy |
+144
| New | +$7.58K | ﹤0.01% | 503 |
|
Other funds holding IDXX
MBI
CGI
CAM
WF
RG
LWCFA
Ledyard National Bank's IDXX Position: Q2 2026 in Review
Ledyard National Bank reduced its Idexx Laboratories (IDXX) stake by 28% in Q2 2026, selling an estimated $105K and leaving 474 shares worth $250K. The position accounts for 0.02% of the portfolio, ranked #229.
Ledyard National Bank first reported a position in IDXX in Q4 2013 and has held it in 37 quarters since. The position peaked at $571K in Q2 2021. 509 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Ledyard National Bank held 474 shares of Idexx Laboratories worth $250K as of Q2 2026.
- Ledyard National Bank sold 187 Idexx Laboratories shares in Q2 2026, an estimated $105K.
- Idexx Laboratories made up 0.02% of Ledyard National Bank's portfolio in Q2 2026, its #229 holding.
- Ledyard National Bank first reported a position in Idexx Laboratories in Q4 2013 and has held it in 37 quarters since.
- Ledyard National Bank's Idexx Laboratories position peaked at $571K in Q2 2021.
- 509 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Ledyard National Bank's 13F filing for Q2 2026, filed 16 Jul 2026.